ANALYSING CLINICAL STUDIES: PRINCIPLES, PRACTICE AND PITFALLS OF KAPLAN–MEIER PLOTS
- 4 February 2008
- journal article
- research article
- Published by Wiley in Anz Journal of Surgery
- Vol. 78 (3) , 204-210
Abstract
The Probelm: The conventional method for estimating survival over time following an episode of disease or treatment is the Kaplan-Meier (K-M) technique, which results in a step-down survival plot, with upper and lower bounds of 1.0 and 0, respectively. The mirror image of this plot represents the cumulative incidence of an adverse event, such as death, with lower and upper bounds of 0 and 1.0, respectively. However, if there are two competing events that can occur during follow up, such as death or relapse, the K-M technique gives a false picture of the cumulative incidence of either one of these events. This occurs because patients who have died cannot subsequently relapse. The Solution: When there are two competing events, another technique must be used, which is known, variously, as cumulative incidence analysis, or 'actual' (as opposed to actuarial) incidence analysis. An example is given in which there are two competing adverse events following haemopoietic stem cell transplantation for a haematological malignancy: (i) relapse or (ii) transplant-related death. Our analysis of the example shows that the cumulative probability of relapse is progressively inflated if the traditional K-M product-limit method is used rather than actual cumulative incidence analysis. We show how K-M and actual cumulative survival or incidence analyses can be executed by a handheld calculator for small datasets or by formulae within a computer spreadsheet for large datasets. Conclusions: Surgical investigators should not use the K-M technique to predict cumulative survival or risk if there are two competing adverse events. They should use, instead, the technique of actual cumulative survival or incidence analysis.Keywords
This publication has 31 references indexed in Scilit:
- Cumulative Incidence in Competing Risks Data and Competing Risks Regression AnalysisClinical Cancer Research, 2007
- Tutorial in biostatistics: competing risks and multi‐state modelsStatistics in Medicine, 2006
- PREOPERATIVE CHEMOTHERAPY AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCERAnz Journal of Surgery, 2005
- Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of ageBlood, 2005
- A note on competing risks in survival data analysisBritish Journal of Cancer, 2004
- Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast CancerNew England Journal of Medicine, 2002
- Competing Risk Analysis After Radical Prostatectomy for Clinically Nonmetastatic Prostate Adenocarcinoma According to Clinical Gleason Score and Patient AgeJournal of Urology, 2002
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- A Stochastic Study of the Life Table and Its Applications. III. The Follow-Up Study with the Consideration of Competing RisksBiometrics, 1961
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958